Skip to main content

Month: December 2020

Delwinds Insurance Acquisition Corporation Announces Pricing of $175,000,000 Initial Public Offering

Houston, TX, Dec. 10, 2020 (GLOBE NEWSWIRE) — Delwinds Insurance Acquisition Corporation (the “Company”) announced today that it priced its initial public offering of 17,500,000 units at $10.00 per unit. The units will be listed on the New York Stock Exchange (“the NYSE”) and trade under the ticker symbol “DWIN.U” beginning December 11, 2020. Each unit consists of one share of the Company’s Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Company expects that its Class A common stock and warrants will be listed on the NYSE under the symbols “DWIN” and “DWIN.WS,” respectively.The Company is a newly organized blank check company...

Continue reading

Senior Connect Acquisition Corp. I Announces Pricing of $360 Million Upsized Initial Public Offering

Scottsdale, AZ , Dec. 10, 2020 (GLOBE NEWSWIRE) — Senior Connect Acquisition Corp. I (the “Company”) announced today the pricing of its initial public offering of 36,000,000 units at a price of $10.00 per unit. The units will be listed on the Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “SNRHU” beginning on December 11, 2020.  Each unit consists of one share of Class A common stock and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one share of Class A common stock at a price of $11.50 per share.  After the securities comprising the units begin separate trading, the shares of Class A common stock and warrants are expected to be listed on Nasdaq under the symbols “SNRH” and “SNRHW,” respectively. The offering is expected...

Continue reading

Equus Announces Pending Sale of Its Interest in Palletone, Inc.

HOUSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Equus Total Return, Inc. (NYSE: EQS) (“Equus” or the “Company”) today announced that the Board of Directors of UFP Industries, Inc. (Nasdaq: UFPI) has approved the purchase of 100% of the equity of PalletOne, Inc. for approximately $232 million. The price assumes a cash free, debt free balance sheet. UFP also agreed to pay $18 million for PalletOne’s recent capital expenditures. The transaction is subject to a net working capital adjustment and is expected to close on December 28, 2020 pending customary closing conditions and regulatory approval.In October 2001, Equus made its initial investment in PalletOne and was one of two institutional funds to finance the creation of PalletOne from certain of the remnants of a former pallet manufacturing conglomerate. PalletOne has since risen to become...

Continue reading

Disclosure of Voting Rights in IDEX Biometrics – Chair Morten Opstad – 10 Dec 2020

At the close of business on 10 December 2020, Morten Opstad, chair of the board of IDEX Biometrics ASA, held the following voting rights in IDEX, for the purpose of the extraordinary general meeting on 15 December 2020:Total 320,687,509 shares or 38.6% of the share capital and votes, consisting of the following:Proxy to represent and vote for 149,774,365 shares or 18.0% of the share capital, including shares held by Mr Opstad and controlled entities.Proxy with voting instructions for 170,913,144 shares or 20.6% of the share capital.For further information contact:Marianne Bøe, Investor RelationsE-mail: marianne.boe@idexbiometrics.comTel: + 47 918 00186Derek P. D’Antilio, Chief Financial OfficerE-mail: derek.dantilio@idexbiometrics.comTel: +1 978 273 1344About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX and OTCQB: IDXAF) is a leading...

Continue reading

Inscape Announces Second Quarter Fiscal 2021 Financial Results

HOLLAND LANDING, Ontario, Dec. 10, 2020 (GLOBE NEWSWIRE) — Inscape (TSX: INQ), a leading designer and manufacturer of furnishings for the workplace, today announced its results of operations for the three and six months ended October 31, 2020 and also announces the addition of a new Board Member representing the company’s largest shareholder, PenderFund Capital Management.“Second Quarter Fiscal Year 2021 results reflect the challenging environment we find ourselves operating in given the COVID-19 pandemic,” said Eric Ehgoetz, CEO. “Management used this environment to launch our new Aria Pronto quick ship wall product in response to the continuing expectations of increased physical separation for work environments. In addition, our team continued with its efforts during the quarter to bring a B2C solution to the work–from–home...

Continue reading

Egan-Jones Recommends Against Electing Dissident’s Full Slate of Nominees to Ziopharm Board

Recommends Against Electing WaterMill Nominee Jaime VieserZiopharm Continues to Recommend that Shareholders Support Company’s Strong Progress by Returning the GREEN Consent Revocation CardBOSTON, Dec. 10, 2020 (GLOBE NEWSWIRE) — Ziopharm Oncology, Inc. (Nasdaq: ZIOP) (“Ziopharm” or the “Company”), today commented on an opinion issued by Egan-Jones Proxy Services (“Egan-Jones”) in connection with the consent solicitation (the “Consent Solicitation”) initiated by WaterMill Asset Management Corp., Mr. Robert W. Postma and certain other individuals (collectively, “WaterMill”). In its report, Egan-Jones recommends that Ziopharm shareholders withhold votes to elect WaterMill’s nominee Jaime Vieser to the Ziopharm Board of Directors (the “Board”), thereby rejecting WaterMill’s attempt to elect their full slate of nominees and seize outsized...

Continue reading

Trulieve Converts Exercise Price of its Listed Warrants to US Dollars

TALLAHASSEE, Fla., Dec. 10, 2020 (GLOBE NEWSWIRE) — Trulieve Cannabis Corp. (CSE: TRUL & OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States, today announced the Company has amended the terms of the issued and outstanding subordinate voting share purchase warrants of the Company (the “Warrants”) to convert the exercise price of the Warrants to USD $13.47 per share, being the US dollar equivalent of the Canadian dollar exercise price of the Warrants of $17.25. The US dollar exercise price was determined using the US dollar exchange rate published by the Bank of Canada as at the close of business on December 9, 2020 of $1.00 = USD $0.781. The Warrants are listed and posted for trading on the Canadian Securities Exchange (the “CSE”) under the symbol “TRUL.WT”. No...

Continue reading

Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.

FDA expected to make a decision on Emergency Use Authorization in the coming daysPositive vote based on totality of scientific evidence presented by the companies, including Phase 3 efficacy and safety dataIf authorized, BNT162b2 would be the first COVID-19 vaccine available in the U.S.NEW YORK and MAINZ, GERMANY, December 10, 2020 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted (17 to 4) in support of the FDA granting Emergency Use Authorization (EUA) for the companies’ COVID-19 mRNA vaccine (BNT162b2). There is one member of the Committee whose vote is not included in the 17 to 4 vote decision.VRBPAC based its recommendation on the totality of scientific evidence shared by the companies,...

Continue reading

FDA-Beratungsausschuss unterstützt die erste U.S.-Notfallzulassung für Pfizers und BioNTechs COVID-19-Impfstoff

FDA wird voraussichtlich innerhalb der nächsten Tage eine Entscheidung bezüglich einer Notfallzulassung treffenDas positive Abstimmungsergebnis basiert auf der Gesamtheit der eingereichten wissenschaftlichen Daten, einschließlich der Phase-3-Daten zu Wirksamkeit und SicherheitIm Falle einer Zulassung wäre BNT162b2 der erste in den USA verfügbare COVID-19-ImpfstoffNEW YORK, USA und MAINZ, Deutschland, 10. Dezember 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) und BioNTech SE (Nasdaq: BNTX) gaben heute bekannt, dass sich das Vaccines and Related Biological Products Advisory Committee (VRBPAC) der U.S. Food and Drug Administration (FDA) für eine Erteilung (17 zu 4 Stimmen) der Notfallzulassung ihres mRNA-basierten COVID-19-Impfstoffs (BNT162b2) durch die FDA ausgesprochen hat. Bei der Abstimmung gab es eine Stimmenthaltung.Das VRBPAC stützt...

Continue reading

Chart Industries’ CEO Evanko Named 2020 Chief Trailblazer of the Year by S&P Global Platts

ATLANTA, Dec. 10, 2020 (GLOBE NEWSWIRE) — Chart Industries, Inc. (NASDAQ: GTLS) is proud to announce that CEO and President Jill Evanko has been awarded the 2020 Chief Trailblazer Award by S&P Global Platts. The S&P Global Platts Global Energy Awards is an annual program that recognizes exemplary corporate and individual innovation, leadership and superior performance. Established in 1999 and often coined “the Oscars” of the energy industry, the S&P Global Platts Global Energy Awards highlight achievement in 21 categories spanning the entire energy complex. This year, there were over 300 nominated entries from over three dozen countries.The Chief Trailblazer Award is awarded to an individual (or to a CEO of a small-mid cap company) who has consistently demonstrated clarity of vision, judgment and motivational skills...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.